# Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis

> **NCT01386827** · PHASE3 · COMPLETED · sponsor: **Helsinki University Central Hospital** · enrollment: 120 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** Mouse brain derived japanese encephalitis vaccine (MB-JEV)
- **BIOLOGICAL:** Primary and booster immunizations with MB-JEV
- **BIOLOGICAL:** C) primary immunizations with Ixiaro
- **BIOLOGICAL:** S) Ixiaro booster to MBJEV primed

## Key facts

- **NCT ID:** NCT01386827
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2011-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386827, "Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01386827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*